224 related articles for article (PubMed ID: 24786124)
1. Evaluation of chromogenic in situ hybridization for the determination of monosomy 3 in uveal melanoma.
Gleeson G; Larkin A; Horgan N; Kennedy S
Arch Pathol Lab Med; 2014 May; 138(5):664-70. PubMed ID: 24786124
[TBL] [Abstract][Full Text] [Related]
2. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
3. Monosomy 3 by FISH in uveal melanoma: variability in techniques and results.
Aronow M; Sun Y; Saunthararajah Y; Biscotti C; Tubbs R; Triozzi P; Singh AD
Surv Ophthalmol; 2012 Sep; 57(5):463-73. PubMed ID: 22658782
[TBL] [Abstract][Full Text] [Related]
4. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
Lake SL; Coupland SE; Taktak AF; Damato BE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
[TBL] [Abstract][Full Text] [Related]
6. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.
Singh AD; Aronow ME; Sun Y; Bebek G; Saunthararajah Y; Schoenfield LR; Biscotti CV; Tubbs RR; Triozzi PL; Eng C
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3331-9. PubMed ID: 22511634
[TBL] [Abstract][Full Text] [Related]
8. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract][Full Text] [Related]
9. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
11. Variation of monosomy 3 status within uveal melanoma.
Schoenfield L; Pettay J; Tubbs RR; Singh AD
Arch Pathol Lab Med; 2009 Aug; 133(8):1219-22. PubMed ID: 19653713
[TBL] [Abstract][Full Text] [Related]
12. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.
Maat W; Jordanova ES; van Zelderen-Bhola SL; Barthen ER; Wessels HW; Schalij-Delfos NE; Jager MJ
Arch Pathol Lab Med; 2007 Jan; 131(1):91-6. PubMed ID: 17227129
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
[TBL] [Abstract][Full Text] [Related]
15. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
16. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
[TBL] [Abstract][Full Text] [Related]
17. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 3 intratumor heterogeneity in uveal melanoma.
Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
[TBL] [Abstract][Full Text] [Related]
20. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
